INVO Bioscience announces 1:20 reverse stock split

INVO Bioscience announced that it will effect a 1-for-20 reverse split of its issued and outstanding and authorized common stock effective as of 12:01 a.m. Eastern Time on July 28. Commencing with the opening of trading on The Nasdaq Capital Market on July 28, the company’s common stock will trade on a post-split basis under the same trading symbol, “INVO“.